Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line

Hepatology

Volumn 42, Issue 4, 2005, Pages 935-945

  Wang, Xin Maggie ^a   Yu, Denise Ming Tse ^a   McCaughan, Geoffrey W ^a   Gorrell, Mark D ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN ANTIBODY; ANTIBODY; BETA CATENIN; BETA1 INTEGRIN; COLLAGEN 1 ANTIBODY; COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGENASE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV ANTIBODY; FIBROBLAST ACTIVATION PROTEIN; FIBROBLAST ACTIVATION PROTEIN ANTIBODY; FIBRONECTIN; FIBRONECTIN ANTIBODY; GELATINASE A; GELATINASE A ANTIBODY; GLUTAMATE RECEPTOR; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; INTEGRIN BETA1 ANTIBODY; LIVER PROTEIN; MATRIGEL; PHALLOIDIN ALEXA FLUOR 594 ANTIBODY; SCLEROPROTEIN; SERINE; STAUROSPORINE; TISSUE INHIBITOR OF METALLOPROTEINASE 2 ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN 293T; CELL STRAIN LX 2; CHRONIC LIVER DISEASE; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER INJURY; LIVER REGENERATION; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STELLATE CELL; STREPTOMYCES; STRUCTURE ACTIVITY RELATION; TISSUE REMODELING; TISSUE REPAIR; WOUND HEALING;

ANTIGENS, CD26; ANTIGENS, NEOPLASM; APOPTOSIS; CELL ADHESION; CELL DIVISION; CELL LINE; CELL MOVEMENT; COLLAGEN TYPE I; CYTOSKELETON; FIBRONECTINS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HUMANS; PHENOTYPE; RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 25844455319     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20853     Document Type: Article

References (48)

1. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloprotcinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002; 277:11069-11076.
2. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38(Suppl 1):S38-S53.
3. Gorrell MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin Sci 2005;108:277-292.
4. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein: a dual-specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999; 274:36505-36512.
5. Levy MT, McCaughan GW, Abbott CA, Park JL, Cunningham AM, Rettig WJ, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. HEPATOLOGY 1999;29:1768-1778.
6. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A 1994;91:5657-5661.
7. Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU, et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol 2003; 120:182-188.
8. Abbott CA, Gorrell MD: The family of CD26/DPIV and related ectopeptidases. In: Langner J, Ansorge S, eds. Ectopeptidases: CD13/Aminopeptidase N and CD26/Dipeptidylpeptidase IV in Medicine and Biology. New York: Kluwer/Plenum, 2002:171-195.
9. Levy MT, McCaughan GW, Marinos G, Gorrell MD. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver 2002; 22:93-101.
10. Hartel-Schenk S, Gossrau R, Reutter W. Comparative immunohistochemistry and histochemistry of dipeptidyl peptidase IV in rat organ: during development. Histochem J 1990;22:567-578.
11. Gorrell MD, Gysbers V, McCaughan GW. CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 2001;54:249-264.
12. Matsumoto Y, Bishop GA, McCaughan GW. Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. HEPATOLOGY 1992;15:1048-1053.
13. Gonzalez-Gronow M, Grenett HE, Weber MR, Gawdi G, Pizzo SV. Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem J 2001;355:397-407.
14. Lambeir AM, Proost P, Durinx C, Bal G, Senten K, Augustyns K, et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 2001;276:29839-29845.
15. Cheng HC, Abdel-Ghany M, Pauli BU. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 2003;278:24600-24607.
16. Hanski C, Huhle T, Reutter W. Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe Seyler 1985;366:1169-1176.
17. Seth D, Leo MA, McGuinness PH, Lieber CS, Brennan Y, Williams RB, et al. Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol 2003;163:2303-2317.
18. Cox G, Kable E, Jones A, Fraser I, Manconi F, Gorrell MD. Three-dimensional imaging of collagen using second harmonic generation. J Struct Biol 2003;141:53-62.
19. Ajami K, Abbott CA, Obradovic M, Gysbers V, Kähne T, McCaughan GW, et al. Structural requirements for catalysis, expression and dimerisation in the CD26/DPIV gene family. Biochemistry 2003;42:694-701.
20. Ajami K, Abbott CA, McCaughan GW, Gorrell MD. Dipeptidyl peptidase 9 is cytoplasmic and has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. Biochem Biophys Acta 2004;1679:18-28.
21. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005;54:142-151.
22. Spizz G, Blackshear PJ. Overexpression of the myristoylated alanine-rich C-kinase substrate inhibits cell adhesion to extracellular matrix components. J Biol Chem 2001;276:32264-32273.
23. Huttenlocher A, Lakonishok M, Kinder M, Wu S, Truong T, Knudsen KA, et al. Integrin and cadherin synergy regulates contact inhibition of migration and motile activity. J Cell Biol 1998;141:515-526.
24. Iron Y, Takamura A, Ito N, Marti Y, Sato H, Suenaga N, et al. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 2001;20:4782-4793.
25. Ko JK, Lee MJ, Cho SH, Cho JA, Lee BY, Koh JS, et al. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 2003;22:2457-2465
26. Zoumi A, Yeh A, Tromberg BJ. Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescence. Proc Natl Acad Sci U S A 2002;99:11014-11019.
27. Wesley UV, Albino AP, Tiwari S, Houghton AN. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 1999;190:311-322.
28. Slimane TA, Lenoir C, Bello V, Delaunay JL, Goding JW, Chwetzoff S, et al. The cytoplasmic/transmembrane domain of dipeptidyl peptidase IV, a type II glycoprotein, contains an apical targeting signal that does not specifically interact with lipid rafts. Exp Cell Res 2001;270: 45-55.
29. Abbott CA, McCaughan GW, Gorrell MD. Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett 1999;458:278-284.
30. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holrhaus K, et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159.
31. Xu Z, Shen MX, Ma DZ, Wang LY, Zha XL. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-betal-enhanced cell migration in SMMC-7721 cells. Cell Res 2003; 13:343-350.
32. Sato K, Aytac U, Yamochi T, Ohnuma K, McKee KS, Morimoto C, et al. CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br J Cancer 2003;89:1366-1374.
33. Aldinucci D, Poletto D, Lorenzon D, Nanni P, Degan M, Olivo K, et al. CD26 expression correlates with a reduced sensitivity to 2′- deoxycoformycin-induced growth inhibition and apoptosis in T-cell leukemia/lymphomas. Clin Cancer Res 2004;10:508-520.
34. Mizokami Y, Kajiyama H, Shibara K, Ino K, Kikkawa F, Mizutani S. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer 2004;110:652-659.
35. Wesley UV, Tiwari S, Houghton AN. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 2004;109:855-866.
36. Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S. Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res 2003; 63:2278-2283.
37. Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T. Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol 2004;172:2332-2340.
38. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002; 160:641-654.
39. Harris TJC, Peifer M. Decisions, decisions: β-catenin chooses between adhesion and transcription. Trends Cell Biol 2005;15:234-237.
40. Mueller SC, Ghersi G, Akiyama SK, Sang QXA, Howard L, Pineiro-Sanchez M, et al. A novel protease-docking function of integrin at invadopodia. J Biol Chem 1999;274:24947-24952.
41. Alahari SK, Lee JW, Juliano RL. Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration. J Cell Biol 2000;151:1141-1154.
42. Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein Alpha. J Biol Chem 2005;280:19441-19444.
43. Artym VV, Kindzelskii AL, Chen WT, Petty HR. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 2002;23:1593-1601.
44. Luo J, Lubaroff DM, Hendrix MJ. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res 1999;59:3552-3556.
45. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 2004;23: 5435-5446.
46. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121:685-698.
47. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001;21:437-451.
48. Pethiyagoda CL, Welch DR, Fleming TP. Dipeptidyl peptidase IV (DP-PIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis 2001;18:391-400.